Thousands Of Americans Died From H1N1 Even After Receiving Vaccine shots

flu virusBy Mike Adams, the Health Ranger, at NaturalNews:

The CDC is engaged in a very clever, statistically devious spin campaign, and nearly every journalist in the mainstream media has fallen for its ploy. No one has yet reported what I’m about to reveal here.

It all started with the CDC’s recent release of new statistics about swine flu fatalities, infection rates and vaccination rates. According to the CDC:

• 61 million Americans were vaccinated against swine flu (about 20% of the U.S. population). The CDC calls this a “success” even though it means 4 out of 5 people rejected the vaccines.

• 55 million people “became ill” from swine flu infections.

• 246,000 Americans were hospitalized due to swine flu infections.

• 11,160 Americans died from the swine flu.

Base on these statistics, the CDC is now desperately urging people to get vaccinated because they claim the pandemic might come back and vaccines are the best defense.

But here’s the part you’re NOT being told.

The CDC statistics lie by omission. They do not reveal the single most important piece of information about H1N1 vaccines: How many of the people who died from the swine flu had already been vaccinated?

Many who died had already been vaccinated

The CDC is intentionally not tracking how many of the dead were previously vaccinated. They want you (and mainstream media journalists) to mistakenly believe that ZERO deaths occurred in those who were vaccinated. But this is blatantly false. Being vaccinated against H1N1 swine flu offers absolutely no reduction in mortality from swine flu infections.

And that means roughly 20% of the 11,160 Americans who died from the swine flu were probably already vaccinated against swine flu. That comes to around 2,200 deaths in people who were vaccinated!

How do I know that swine flu vaccines don’t reduce infection mortality? Because I’ve looked through…

[continues at NaturalNews]

, ,

  • http://www.howtostaymarried.net Phillip Landry

    doublepost.

  • http://www.howtostaymarried.net Phillip Landry

    Does that mean the vaccine was useless? I just had my vaccine shot 2 months ago and I don't want to die when I think I was going to be alright.. probably the vaccines made the flu worse?

  • http://profiles.yahoo.com/u/PDDVWRQVUPMKRGHURIEQVNYWHQ Sean

    I'd like to see numbers on % of vaccinated people who died vs. % of unvaccinated who died

  • Sheldon Nylander

    It takes ten days after being vaccinated for the immunity to be built up. If these people got infected before being vaccinated or after but before the had a chance to build up immunity, then this is a non-story. It's not about reducing mortality. It's about reducing infection rates, which lead to mortality. And of course there have been no double-blind studies. While that's the gold standard in science, doing that with vaccines would by morally and ethically reprehensible, because that would require deliberately infecting people with a dangerous disease (instead of giving them a vaccine, you give them a live, unhindered virus). However, there are years of convergent evidence that show that vaccines do work, and they do reduce infection rates.

  • tonyviner

    I'm no Alex Jones or anything, but something is definitely amiss here. The New World Order and all of that stuff…

  • aeauooo

    Mr. Adams, you wrote, “The CDC is engaged in a very clever, statistically devious spin campaign.” May I ask, is your statistical spin any less devious? You fail to mention that the majority of the 61 million H1N1 vaccine recipients were among the initial target group of 160 million persons. The H1N1 vaccine was only recently made available to the general public; therefore, your statement that “80% of Americans refused to get vaccinated against swine flu” is a canard.

    It is true that the efficacy of influenza vaccines in preventing mortality in individuals over 65 years of age is in question. What is not in question is the efficacy of influenza vaccines preventing morbidity in individuals under 65 years of age. Since the majority of influenza deaths usually occur in those over 65, the effect of an influenza vaccine on overall mortality may seem negligible. Keep in mind that healthy people over 65 years of age were not in the initial target group and, like the rest of healthy individuals in the U.S., have not been eligible for H1N1 immunization until a few weeks ago.

    Based upon these omissions from your analysis, your conclusions that “thousands of Americans died from H1N1 even after receiving vaccine shots” is yet another canard.

  • aeauooo

    I had some time to conduct a proper literature search today on the medical library website to which I have access. I searched ‘influenza vaccine’ and limited my search to ‘randomized controlled trials’ in the last 20 years. There were 480 results. To be fair, many of them were phase I and phase II clinical trials (premarketing) of new vaccines and safety and efficacy trial in different populations.

    I find it interesting that Mr. Adams claims there are ZERO randomized controlled trials on influenza vaccine safety and efficacy when in a matter of minutes I found no less than a dozen (see below) conducted in the last two years on influenza vaccines currently licensed in the U.S.

    Perhaps Mr. Adams does not have access to a university medical library, as I do, but he can certainly search PubMed and read the abstracts of hundreds of RCTs on influenza and other vaccines.

    Zhu FC., Wang H., Fang HH., Yang JG., Lin XJ., Liang XF., et al. (2009). A novel influenza A (H1N1) vaccine in various age groups. New England Journal of Medicine, 361(25):2414-2423.

    Greenberg ME., Lai MH., Hartel GF., Wichems CH., Gittleson C., Bennet J., et al. (2009). Response to a monovalent 2009 influenza A (H1N1) vaccine. New England Journal of Medicine, 361(25):2405-2413.

    Beran J., Vesikari T., Wertzova V., Karvonen A., Honegr K., Lindblad N., et al. (2009). Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. Journal of Infectious Diseases, 200(12):1861-1869.

    Lemaitre M., Meret T., Rothan-Tondeur M., Belmin J., Lejonc JL., Luquel L., et al. (2009). Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. Journal of the American Geriatrics Society, 57(9):1580-1586.

    Monto AS., Ohmit SE., Petrie JG., Johnson E., Truscon R., Teich E., et al. (2009). Comparative efficacy of inactivated and live attenuated influenza vaccines. New England Journal of Medicine, 361(13):1260-1267.

    MacDonald NE., Riley LE., Steinhoff MC. (2009). Influenza immunization in pregnancy. Obstetrics & Gynecology, 114(2 Pt 1):365-368.

    Bracco Neto H., Farhat CK., Tregnaghi MW., Madhi SA., Razmpour A., Palladino et al. (2009). Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Pediatric Infectious Disease Journal, 28(5):365-371.

    Ohmit SE., Gross J., Victor JC., Monto AS.(2009). Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination. Vaccine, 27(7):1050-1054.

    Zaman K., Roy E., Arifeen SE., Rahman M., Raqib R., Wilson E., et al. (2008). Effectiveness of maternal influenza immunization in mothers and infants. New England Journal of Medicine, 359(15):1555-1564.

    Levin MJ., Song LY., Fenton T., Nachman S., Patterson J., Walker R. et al. (2008). Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine, 26(33):4210-4217.

    Talbot HK., Keitel W., Cate TR., Treanor J., Campbell J., Brady RC., et al. (2008). Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine, 26(32):4057-4061.

    Vesikari T., Karvonen A., Smith HM., Dunning A., Razmpour A., Saville MK., et al. (2008).
    Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age. Pediatrics, 121(3):e568-573.

    Hibbert CL., Piedra PA., McLaurin KK., Vesikari T., Mauskopf J., Mahadevia PJ. (2007). Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine, 25(47):8010-8020.

    Couch RB., Winokur P., Brady R., Belshe R., Chen WH., Cate TR., et al. (2007). Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine. 25(44):7656-7663.

    I’d be more than happy to query Mr. Adams about my concerns regarding the inaccuracies found in his article, but I didn’t find his Email address on the Natural News website.

  • aeauooo

    I had some time to conduct a proper literature search today on the medical library website to which I have access. I searched ‘influenza vaccine’ and limited my search to ‘randomized controlled trials’ in the last 20 years. There were 480 results. To be fair, many of them were phase I and phase II clinical trials (premarketing) of new vaccines and safety and efficacy trial in different populations.

    I find it interesting that Mr. Adams claims there are ZERO randomized controlled trials on influenza vaccine safety and efficacy when in a matter of minutes I found no less than a dozen (see below) conducted in the last two years on influenza vaccines currently licensed in the U.S.

    Perhaps Mr. Adams does not have access to a university medical library, as I do, but he can certainly search PubMed and read the abstracts of hundreds of RCTs on influenza and other vaccines.

    Zhu FC., Wang H., Fang HH., Yang JG., Lin XJ., Liang XF., et al. (2009). A novel influenza A (H1N1) vaccine in various age groups. New England Journal of Medicine, 361(25):2414-2423.

    Greenberg ME., Lai MH., Hartel GF., Wichems CH., Gittleson C., Bennet J., et al. (2009). Response to a monovalent 2009 influenza A (H1N1) vaccine. New England Journal of Medicine, 361(25):2405-2413.

    Beran J., Vesikari T., Wertzova V., Karvonen A., Honegr K., Lindblad N., et al. (2009). Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. Journal of Infectious Diseases, 200(12):1861-1869.

    Lemaitre M., Meret T., Rothan-Tondeur M., Belmin J., Lejonc JL., Luquel L., et al. (2009). Effect of influenza vaccination of nursing home staff on mortality of residents: a cluster-randomized trial. Journal of the American Geriatrics Society, 57(9):1580-1586.

    Monto AS., Ohmit SE., Petrie JG., Johnson E., Truscon R., Teich E., et al. (2009). Comparative efficacy of inactivated and live attenuated influenza vaccines. New England Journal of Medicine, 361(13):1260-1267.

    MacDonald NE., Riley LE., Steinhoff MC. (2009). Influenza immunization in pregnancy. Obstetrics & Gynecology, 114(2 Pt 1):365-368.

    Bracco Neto H., Farhat CK., Tregnaghi MW., Madhi SA., Razmpour A., Palladino et al. (2009). Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children. Pediatric Infectious Disease Journal, 28(5):365-371.

    Ohmit SE., Gross J., Victor JC., Monto AS.(2009). Reduced reaction frequencies with repeated inactivated or live-attenuated influenza vaccination. Vaccine, 27(7):1050-1054.

    Zaman K., Roy E., Arifeen SE., Rahman M., Raqib R., Wilson E., et al. (2008). Effectiveness of maternal influenza immunization in mothers and infants. New England Journal of Medicine, 359(15):1555-1564.

    Levin MJ., Song LY., Fenton T., Nachman S., Patterson J., Walker R. et al. (2008). Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine, 26(33):4210-4217.

    Talbot HK., Keitel W., Cate TR., Treanor J., Campbell J., Brady RC., et al. (2008). Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine, 26(32):4057-4061.

    Vesikari T., Karvonen A., Smith HM., Dunning A., Razmpour A., Saville MK., et al. (2008).
    Safety and tolerability of cold-adapted influenza vaccine, trivalent, in infants younger than 6 months of age. Pediatrics, 121(3):e568-573.

    Hibbert CL., Piedra PA., McLaurin KK., Vesikari T., Mauskopf J., Mahadevia PJ. (2007). Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. Vaccine, 25(47):8010-8020.

    Couch RB., Winokur P., Brady R., Belshe R., Chen WH., Cate TR., et al. (2007). Safety and immunogenicity of a high dosage trivalent influenza vaccine among elderly subjects. Vaccine. 25(44):7656-7663.

    I’d be more than happy to query Mr. Adams about my concerns regarding the inaccuracies found in his article, but I didn’t find his Email address on the Natural News website.

21